1. Home
  2. PTGX vs LILAK Comparison

PTGX vs LILAK Comparison

Compare PTGX & LILAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • LILAK
  • Stock Information
  • Founded
  • PTGX 2006
  • LILAK 2017
  • Country
  • PTGX United States
  • LILAK Bermuda
  • Employees
  • PTGX N/A
  • LILAK N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • LILAK Cable & Other Pay Television Services
  • Sector
  • PTGX Health Care
  • LILAK Telecommunications
  • Exchange
  • PTGX Nasdaq
  • LILAK Nasdaq
  • Market Cap
  • PTGX 4.0B
  • LILAK 1.7B
  • IPO Year
  • PTGX 2016
  • LILAK N/A
  • Fundamental
  • Price
  • PTGX $78.62
  • LILAK $7.91
  • Analyst Decision
  • PTGX Strong Buy
  • LILAK Hold
  • Analyst Count
  • PTGX 9
  • LILAK 2
  • Target Price
  • PTGX $78.11
  • LILAK $7.85
  • AVG Volume (30 Days)
  • PTGX 1.6M
  • LILAK 696.8K
  • Earning Date
  • PTGX 10-31-2025
  • LILAK 11-05-2025
  • Dividend Yield
  • PTGX N/A
  • LILAK N/A
  • EPS Growth
  • PTGX N/A
  • LILAK N/A
  • EPS
  • PTGX 0.80
  • LILAK N/A
  • Revenue
  • PTGX $209,180,000.00
  • LILAK $4,409,700,000.00
  • Revenue This Year
  • PTGX N/A
  • LILAK $1.35
  • Revenue Next Year
  • PTGX $142.86
  • LILAK N/A
  • P/E Ratio
  • PTGX $97.73
  • LILAK N/A
  • Revenue Growth
  • PTGX N/A
  • LILAK N/A
  • 52 Week Low
  • PTGX $33.31
  • LILAK $4.23
  • 52 Week High
  • PTGX $93.25
  • LILAK $10.67
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 61.88
  • LILAK 44.15
  • Support Level
  • PTGX $73.08
  • LILAK $7.61
  • Resistance Level
  • PTGX $79.00
  • LILAK $8.79
  • Average True Range (ATR)
  • PTGX 2.39
  • LILAK 0.32
  • MACD
  • PTGX -0.24
  • LILAK -0.06
  • Stochastic Oscillator
  • PTGX 93.42
  • LILAK 25.83

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: